Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
ID BIOMEDICAL CORPORATION
| ID BIOMEDICAL CORPORATION Patent applications | ||
| Patent application number | Title | Published |
|---|---|---|
| 20110182923 | NOVEL GROUP B STREPTOCOCCUS ANTIGENS | 07-28-2011 |
| 20100119507 | STREPTOCOCCUS PYOGENES ANTIGENS AND CORRESPONDING DNA FRAGMENTS - The present invention relates to antigens, more particularly antigenS of | 05-13-2010 |
| 20100093035 | NOVEL STREPTOCOCCUS ANTIGENS - proteins and polynucleotides encoding them are disclosed. Said proteins are antigenic and therefore useful vaccine components for the prophylaxis or therapy of | 04-15-2010 |
| 20090186820 | STREPTOCOCCUS PYOGENES POLYPEPTIDES AND CORRESPONDING DNA FRAGMENTS - The present invention relates to antigens, more particularly antigens of | 07-23-2009 |
| 20090074807 | MORAXELLA (BRANHAMELLA) CATARRHALIS ANTIGENS - The present invention relates to polypeptides of | 03-19-2009 |
| 20090042794 | GROUP B STREPTOCOCCUS ANTIGENS AND CORRESPONDING DNA FRAGMENTS - The present invention relates to antigens, more particularly antigens of Group B | 02-12-2009 |
| 20080254067 | Process for the Production of an Influenza Vaccine - The present invention relates to a commercial-scale process for the production of influenza virus or antigens for prophylactic, diagnostic, immunotherapeutic or therapeutic purposes. Particularly, the invention provides a Madin-Darby Canine Kidney (MDCK)-derived, cell line and a cell culture-based process for the production of an influenza vaccine and more particularly, a human vaccine comprising influenza types A and B. | 10-16-2008 |
| 20080227706 | BVH-A2 AND BVH-A3 ANTIGENS OF GROUP B STREPTOCOCCUS | 09-18-2008 |